UCB Windlesham
In 2021, the studio was approached to design a global research hub that will develop treatments for severe neurological and immunological diseases. Situated on a 47-acre site in rural Surrey, Southeast England, the project, also known as the Early Discovery Campus, will be the new UK home of Belgian life sciences company UCB. Our brief was to create a stimulating post-Covid environment for the company’s staff, who require a collaborative and cutting-edge facility for research into, and early manufacture of, life-changing treatments for conditions such as Parkinson’s disease, epilepsy, arthritis, and osteoporosis. The site was previously home to another pharmaceutical company, and we are refurnishing and repurposing three of the existing laboratory buildings that remain from that time. These will be connected to a new three-storey timber and zinc-clad structure called ‘The Brain’, partially embedded within the earth. This 2,900 square metre building will feature a large atrium overlooked by sculptural balconies on the upper floors.
Перейти к оригиналу
